OncLive Competitors

Springer Nature publishes journals, databases and online products and services across the life, physical and applied sciences and, most recently, clinical medicine. Content encompasses daily news from award-winning journalists, expert opinion and practical methodology, and more high impact research and reviews than any science publisher. Over 70 journals are published, some in association with prestigious academic societies. Nature Portfolio provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs. Nature was first published in 1869. Springer Nature has its principal offices in London, New York and Tokyo with offices in offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC.

Founded in 1964, the American Society of Clinical Oncology (ASCO) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 50,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest quality care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO’s Conquer Cancer Foundation supports the Society by funding groundbreaking research and education across cancer’s full continuum. Learn more at www.ASCO.org. Use of our LinkedIn page is subject to our Social Media Policy (http://www.asco.org/about-asco/legal/social-media-policy) as well as applicable policies of LinkedIn

The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration, and data-driven innovation. Since 1953, CRI has empowered researchers to uncover how the immune system can fight cancer - and helped transform bold scientific ideas into treatments. We fund breakthrough research at every stage, from fundamental immunology to clinical translation. Our global ecosystem supports young investigators, accelerates high-risk, high-reward ideas, and promotes collaboration between academia, biotech, and industry. Our mission is to create a world immune to cancer by driving scientific discovery, accelerating collaboration, and turning breakthroughs into life-saving treatments. Our work bridges the gap between discovery and patient impact, ensuring that scientific innovation translates into real-world treatments. 🌐Discover how CRI is fueling discoveries: cancerresearch.org 🔬 Join our scientific community: fellowships, grants, and global collaboration opportunities 📢 Follow us for updates on research breakthroughs, inspiring patient stories, and funding announcements CRI welcomes your comments and community participation, but reminds you to be careful about posting sensitive information about yourself or others. CRI is not responsible for the use, reproduction, or distribution of publicly posted information, and by posting such information you hereby indemnify and release CRI from any liability arising from such disclosure.